黃柏松 Po-Sung (Sinclair) Huang#
資深產業經營者｜企業成長與轉型顧問｜獨立研究者#
從市場機會與企業策略出發，連結產品與技術方向、資本配置、營運能力及組織執行。
黃柏松（Po-Sung / Sinclair Huang）是一位資深產業經營者，擁有逾三十年於上市公司的高階經營經驗，產業橫跨電子、工業材料、化工與生命科學。
其職涯歷任多家上市公司之財務長、執行副總、總經理與事業群財務經管主管，曾任職於鴻海科技集團（Foxconn）、元太科技（E Ink）、國際中橡（CSRC）等企業，任職期間歷經企業從成長、規模化到轉型的不同階段。這些職務的共同點，是必須同時面對市場位置、產品與技術方向、資本配置、營運能力與組織執行——策略能否成立，取決於這幾件事能否接得起來。
其顧問服務聚焦於企業成長、轉型與重大決策：從市場機會與企業策略出發，連結產品與技術方向、資本配置、營運能力及組織執行。財務分析、流程改善、資料分析與 AI 是用來驗證判斷、解除瓶頸的工具，而不是顧問工作的起點或邊界。決策權與執行責任留在企業管理團隊。
在顧問工作之外，他以獨立研究者身分持續研究 AI、半導體、先進材料與資本配置。這些是目前研究與顧問判斷所關注的領域；研究支撐判斷，而不取代它。
策略視角#
企業經營與跨功能判斷
歷任上市公司之財務、策略、營運與組織管理等高階職務，責任範圍涵蓋市場與客戶、產品與技術方向、資本配置、營運能力與組織執行。具備在證據尚不完整時界定問題並作出決策的實務判斷。
成長、轉型與重大決策
顧問服務聚焦於跨部門、無法由單一功能獨立解決的問題：獲利成長、競爭位置、重大投資與融資、產能與布局，以及執行所需的組織能力。顧問提供獨立判斷與決策架構，決策權與執行責任留在企業管理團隊。
AI、資本與產業轉型
目前的研究關注 AI 與產業變遷如何重新分配價值、改變競爭格局。在顧問工作中，AI 是協助企業處理經營問題、驗證判斷與改善決策的工具，而不是顧問工作的起點或邊界；技術建置由適當的內部團隊或技術夥伴負責。
了解顧問服務 → ｜ 查看研究發表 →
English Summary#
Senior Industry Executive | Growth & Transformation Advisor | Independent Researcher
Connecting market opportunity and business strategy with product and technology direction, capital allocation, operating capability and organisational execution.
Po-Sung (Sinclair) Huang is a senior industry executive with more than 30 years of senior management experience in publicly listed companies, across electronics, industrial materials, chemicals and life sciences. He has served as CFO, Executive Vice President and General Manager, as well as in group-level finance and business-management leadership roles, through periods of growth, scaling and transformation.
His advisory focus is growth, transformation and major business decisions: where a business should compete, which products and capabilities deserve investment, how capital should be committed, and whether the organisation can execute. Financial analysis, process improvement, data analysis and AI are tools used to test judgement and clear bottlenecks — not the starting point or the boundary of the work. Decision rights and execution responsibility stay with the company’s management team.
His independent research focuses on AI, semiconductors, advanced materials and capital allocation. This research informs, rather than defines, his advisory perspective.
Advisory services → | Full profile →
Selected Work#
View All Publications → | ORCID: 0009-0007-8173-5672
Customer prepayments, HBM margin structure, capital expenditure intensity — the numbers say more than the narratives do. Series: AI Compute Supply Chain | Part 3 of 5
By Po-Sung(Sinclair) Huang
The previous article built a framework. This one tests it with documents.
Before writing this piece, I set aside the analyst summaries and went to the source: TSMC’s 2024 20-F filed with the SEC on April 17, 2025; Micron’s most recent 10-K and two 10-Q filings; and SK Hynix earnings call transcripts for the past three quarters.
...
What EDM Reveals About the Twin Structure of Scientific Innovation
EDM is not just a better academic metric. It points to a deeper truth: real breakthroughs often emerge through parallel convergence, not singular genius.
A new paper on the Embedding Disruptiveness Measure (EDM) — a method designed to detect truly disruptive science — raises an old question: why do we remember breakthroughs as if they belonged to one person?
In recent weeks, much of my writing has focused on AI infrastructure, supply-chain leverage, and the hidden concentration of power beneath the semiconductor stack. But behind those industrial bottlenecks lies a deeper upstream question that has stayed with me: how do real breakthroughs actually emerge, and why are they so often remembered as the victory of a single name?
...
From TSMC to SK Hynix to Ajinomoto — who holds pricing power, and who is just riding the narrative?
Series: AI Compute Supply Chain | Part 2 of 5
Author: Po-Sung(Sinclair) Huang
The first article in this series explained what CoWoS, HBM, and ABF are.
This one answers the harder question underneath: who controls them?
Knowing that these three layers matter is the entry ticket. The real analytical edge comes from understanding who in each layer has the power to say no — and what happens to the whole chain when they do.
...
AlphaFold helped us predict what proteins look like. The next wave of models is starting to address something harder: how proteins move, switch states, and perform functions over time.*
By Po-Sung(Sinclair) Huang
AlphaFold changed protein science by helping researchers predict what proteins look like with unprecedented scale and accuracy. But proteins do not function as frozen objects. They bend, vibrate, open pockets, switch conformations, and transmit signals across time.
That is why the next frontier after structure may be something more difficult and more consequential: behaviour.
...
A new working paper suggests that markets often reward narrative clarity more than scientific spillovers.
By Po-Sung(Sinclair) Huang
We like to think capital markets reward great science.
In biopharma, that is only partly true.
In a new working paper, I compare market capitalisation with forward citations — a proxy for how much others are actually using a firm’s research. What emerges is not a smooth relationship, but a striking pricing gap.
...
Why is everyone suddenly talking about CoWoS, HBM, and ABF whenever AI, NVIDIA, or AI servers come up? Many people know they are important, but still get stuck the first time they run into these terms.
This essay is a plain‑language walkthrough of what they actually are, why they are always mentioned together, and how they map onto Taiwan’s role in the global AI supply chain.
When Google, Amazon, and Tesla are all designing their own chips, is Taiwan’s manufacturing ecosystem still structurally important — or just enjoying a temporary window?
...
Every layer that looks solved hides another constraint beneath it.
§1 The Illusion of Infinite Compute The headlines say NVIDIA is winning. The hyperscalers are spending. The models are getting bigger.
But the real question is not where demand is going. It is where compute, physically, can still be built fast enough to meet it.
The harder answer requires tracing the full physical stack — from silicon wafer, through memory stack, through packaging interposer, through substrate material — and asking at each layer: can this actually scale at the speed the demand curve requires?
...
AI in drug discovery is often framed as a speed story. Faster screening, faster structure prediction, faster candidate generation.
But speed is only the surface.
What AI really changes is the way search space is organized. In traditional drug discovery, much of the challenge lies not only in testing compounds, but in deciding where to look. AI expands the ability to navigate vast biological and chemical spaces, but it does not eliminate the underlying uncertainty of biology itself.
...
For years, digital strategy was built around owning traffic and bringing users back to a company website.
That logic may be weakening.
As AI systems become better at summarizing, filtering, comparing, and presenting options directly to users, the key source of value may shift from website ownership to interface control. In other words, the winner may not always be the company with the best homepage, but the company, platform, or system that controls how customer intent is interpreted and how choices are presented.
...
In every wave of commerce, people tend to focus on tools first.
They talk about better platforms, smoother interfaces, lower friction, faster conversion, and now AI-driven recommendation systems. But the first principle of commerce has not changed.
Trust comes before efficiency.
Before a customer asks whether a platform is convenient, they ask whether the product is real, whether the seller is credible, and whether the transaction can be completed safely. This was true in early e-commerce, and it remains true in the AI era.
...